期刊文献+

CYP2C19基因多态性及代谢表型在604例老年冠心病患者中的分布 被引量:8

Analysis of genetic polymorphisms and metabolic phenotype of CYP2C19 in 604 senile patients with coronary heart disease
下载PDF
导出
摘要 目的:探讨老年冠心病患者细胞色素P450 2C19(CYP2C19)基因多态性及代谢表型的分布。方法:应用DNA微阵列芯片法对604例来我院就诊的老年冠心病患者进行CYP2C19基因分型。结果:本研究中检测到CYP2C19的6个不同基因型为:CYP2C19*1/*1,*1/*2,*1/*3,*2/*2,*2/*3,*3/*3,所占比例分别为40.2%、40.9%、6.6%、10.1%、2.0%及0.2%。CYP2C19三种代谢表型:快代谢型、中间代谢型、慢代谢型,所占比例分别为40.2%、47.5%、12.3%。男性:快代谢型占38.0%(168/442),中间代谢型占48.9%,(216/442),慢代谢型13.1%(58/442);女性:快代谢型占46.3%(75/162),中间代谢型占43.8%,(71/162),慢代谢型9.9%(16/162)。结论:604例老年冠心病患者中CYP2C19的基因型分布及代谢表型,与文献报道的中国汉族健康人群基本一致,其在男女间分布差异无统计学意义。 Objective: To investigate the genetic polymorphisms of and metabolic phenotype cytochrome P450 2C19( CYP2C19) in senile patients with coronary heart disease. Methods: The genotypes of CYP2C19 in604 senile patients with coronary heart disease were determined by using DNA microarray method. Results: Six genotypes of CYP2C19 were detected in this study with CYP2C19*1 /*1 accounting for 40. 2%,CYP2C19*1 /*2 40. 9% 、 CYP2C19*1 /*3 6. 6%, CYP2C19*2 /*2 10. 1%, CYP2C19*2 /*3 2. 0%, and CYP2C19*3 /*3 0. 2%. There were three types of metabolic phenotype including rapid metabolism type,intermediate type,and slow type accounting for 40. 2%,47. 5%,and 12. 3%,respectively. In male patients,the percentage of the three types of metabolic phenotype was 38. 0%( 168 /442),48. 9%( 216 /442),13. 1%( 58 /442) respectively,and 46. 3%,43. 8%( 71 /162),9. 9%( 16 /162) respectively in female patients. Conclusion: The distribution of CYP2C19 genotypes in 604 senile patients with coronary heart disease is consistent with that in Han population of different age. There is no significant difference between male and female patients.
出处 《心肺血管病杂志》 2015年第12期887-889,共3页 Journal of Cardiovascular and Pulmonary Diseases
关键词 CYP2C19 基因多态性 代谢表型 微阵列芯片法 老年冠心病 CYP2C19 Genetic polymorphisms Metabolic phenotype Microarray method Senile coronary heart disease
  • 相关文献

参考文献9

二级参考文献60

共引文献78

同被引文献86

  • 1周健,吕虹,康熙雄.中国汉族人群不同性别、年龄、体重指数之间细胞色素氧化酶CYP2C19基因多态性的检测[J].中国临床药理学与治疗学,2007,12(2):208-213. 被引量:84
  • 2Bozbeyoglu E,Satilmis S,Aksu H, et al. Impact of clopi- dogrel resistance on ST-segment resolution and no-reflow in acute myocardial infarction with ST-elevation patients treated with a primary percutaneous coronary intervention [J]. Coronary Artery Disease, 2012,23 (8) : 108-111.
  • 3Samos M,Simonova R,Kovar F,et al. Clopidogrel resistance in diabetic patient with acute myocardial infarction due to stent thrombosis [J]. Am J Emerg Med, 2014,32 (5) : 461- 465.
  • 4Sambu N,Radhakrishnan A, Dent H,et al. Personalised an- tiplatelettherapy in stent thrombosis:observations from the Clopidogrel Resistance in Stent Thrombosis (CREST)reg-istry [J]. Heart, 2012,98 (9) : 706-711.
  • 5Ma TK, Lam YY,Tan VP, et al.Impaet of genetic and ac- quired alteration incytochrome P450 system on pharmaco- logic and clinical response to clopidogrel [J]. Pharmacol Ther,2010, 125(2) :249-259.
  • 6Sibbing D,Stegherr J,Latz W, et al. Cytochrome P4502C 19loss- of-function polymorphism and stent thrombosis following percutaneous coronary intervention [J]. Eur Heart J, 2009, 30(8) :916-922.
  • 7Luo Y,Zhao YT,Verdo A,et al.Relationship between Cy- tochrome P4502C19"2 Polymorphism and Stent Thrombo- sis following Percutaneous Coronary Intervention in Chi- nesePatients Receiving Clopidogrel [J]. Journal of Inter- national Medical Research, 2011,39 (5) : 2012-2019.
  • 8Kupstyte N, Zaliunas R, Tatarunas V, et al. Effect of clini- cal factors and gene polymorphism of CYP2C19"2,*17 and CYP4F2*3 on early stent thrombosis [J]. Pharmacoge- nomics,2015,16(3) : 181-189.
  • 9Kazui M, Nishiya Y, Ishizuka T, et al. Identification of the human cytochrome P450 enzymes involved in the two ox- idative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite [J]. Drug Metab Dispos, 2010,38(1) : 92-99.
  • 10Huczek Z,Filipiak KJ,Kochman J,et al. Baseline platelet size is increased in patients with acute coronary syn- dromes de'eloping early stent thrombosis and predictsfu- ture residual platelet reactivity. A case-control study [J]. Thromb Res, 2010,125 (5) : 406-412.

引证文献8

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部